As we start the year, we are devoting the lion’s share of the editorial pages this month to thyroid cancer. From its diagnosis and treatment to detailed studies about hypoparathyroidism, risk stratification for thyroid nodules, and more. With thyroid cancer being the most common endocrine cancer in the world, we thought it would be appropriate... As we start the year, we are devoting the lion’s share of the editorial pages this month to thyroid cancer. From its diagnosis and treatment to detailed studies about hypoparathyroidism, risk stratification for thyroid nodules, and more. With thyroid cancer being the most common endocrine cancer in the world, we thought it would be appropriate...
This month’s issue is an unusual one for us as it focuses on a malady that we seldom focus on in Endocrine News, much less devote an entire issue to it: Steatotic liver disease. Since this condition is destined to reach epidemic proportions along with obesity and diabetes, we felt this was a good time...
It’s not often that diabetes treatments make it into the monologue for the Academy Awards, but on Sunday March 12, that’s exactly what happened. As OSCARS host Jimmy Kimmel began his hosting duties on that star-studded evening, he quipped, “When I look around this room, I can’t help but wonder if Ozempic is right for...
